Results for hiperaldosteronizmom translation from Slovenian to Maltese

Computer translation

Trying to learn how to translate from the human translation examples.

Slovenian

Maltese

Info

Slovenian

hiperaldosteronizmom

Maltese

 

From: Machine Translation
Suggest a better translation
Quality:

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Slovenian

Maltese

Info

Slovenian

Če je kombinacija ramiprila in hidroklorotiazida uporabljena pri bolniku s primarnim hiperaldosteronizmom, je treba natančno kontrolirati koncentracijo kalija v plazmi.

Maltese

jekk ramipril + hydrochlorothiazide jintuża f’ pazjent b’ iperaldosteroniżmu primarju, ikun hemm bżonn ta ’ monitoraġġ bir- reqqa tal- livelli tal- pottasium fil- plażma.

Last Update: 2012-04-12
Usage Frequency: 2
Quality:

Slovenian

primarni hiperaldosteronizem bolniki s primarnim hiperaldosteronizmom se na zdravljenje z antihipertenzivi, ki zavirajo sistem renin- angiotenzin, večinoma ne odzovejo.

Maltese

iperaldosteroniżmu primarju pazjenti b’ aldosteroniżmu primarju ġeneralment mhux ser jirrispondu għal mediċini ta ’ kontra l- pressjoni li jaġixxu b’ impediment fuq is- sistema renin- angiotensin.

Last Update: 2012-04-12
Usage Frequency: 2
Quality:

Slovenian

primarni hiperaldosteronizem bolnikov s primarnim hiperaldosteronizmom ne smete zdraviti z antagonistom angiotenzina ii, valsartanom, ker tem bolnikom osnovna bolezen prizadene sistem renin- angiotenzin.

Maltese

pazjenti b’ kondizzjoni primarja b’ livelli għoljin ta ’ aldosterone pazjenti b’ kondizzjoni primarja b’ livelli għoljin ta ’ aldosterone m’ għandhomx jiġu kurati b’ valsartan li hu antagonist ta ’ angiotensin ii peress li s- sistema ta ’ renin- angiotensin tagħħom hija effettwata mill- marda naturali.

Last Update: 2012-04-12
Usage Frequency: 2
Quality:

Get a better translation with
7,747,310,793 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK